Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial
| Image |  |
|---|---|
| Description | scientific article published on 22 December 2016 |
| Author/s |
author: Hiroji Iwata Norikazu Masuda Junichiro Watanabe Katsumasa Kuroi |
| Publication date | December 22, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |